• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌和肝硬化患者血清中触珠蛋白上完整O-糖肽的定量分析

Quantification of Intact O-Glycopeptides on Haptoglobin in Sera of Patients With Hepatocellular Carcinoma and Liver Cirrhosis.

作者信息

Shu Hong, Zhang Lei, Chen Yiwei, Guo Yijie, Li Limin, Chen Fanghua, Cao Zhao, Yan Guoquan, Lu Chunlai, Liu Chao, Zhang Shu

机构信息

Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China.

Department of Clinical Laboratory, Cancer Hospital of Guangxi Medical University, Nanning, China.

出版信息

Front Chem. 2021 Jul 14;9:705341. doi: 10.3389/fchem.2021.705341. eCollection 2021.

DOI:10.3389/fchem.2021.705341
PMID:34336790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8316590/
Abstract

Haptoglobin (Hp) is one of the acute-phase response proteins secreted by the liver, and its aberrant N-glycosylation was previously reported in hepatocellular carcinoma (HCC). Limited studies on Hp O-glycosylation have been previously reported. In this study, we aimed to discover and confirm its O-glycosylation in HCC based on lectin binding and mass spectrometry (MS) detection. First, serum Hp was purified from patients with liver cirrhosis (LC) and HCC, respectively. Then, five lectins with Gal or GalNAc monosaccharide specificity were chosen to perform lectin blot, and the results showed that Hp in HCC bound to these lectins in a much stronger manner than that in LC. Furthermore, label-free quantification based on MS was performed. A total of 26 intact O-glycopeptides were identified on Hp, and most of them were elevated in HCC as compared to LC. Among them, the intensity of HYEGS TVPEK (H1N1S1) on Hp was the highest in HCC patients. Increased HYEGS TVPEK (H1N1S1) in HCC was quantified and confirmed using the MS method based on O/O C-terminal labeling and multiple reaction monitoring. This study provided a comprehensive understanding of the glycosylation of Hp in liver diseases.

摘要

触珠蛋白(Hp)是肝脏分泌的急性期反应蛋白之一,此前有报道称其在肝细胞癌(HCC)中存在异常的N-糖基化。此前关于Hp O-糖基化的研究较少。在本研究中,我们旨在基于凝集素结合和质谱(MS)检测来发现并确认其在HCC中的O-糖基化。首先,分别从肝硬化(LC)患者和HCC患者中纯化血清Hp。然后,选择五种对Gal或GalNAc单糖具有特异性的凝集素进行凝集素印迹分析,结果显示HCC中的Hp与这些凝集素的结合比LC中的更强。此外,基于MS进行了无标记定量分析。在Hp上共鉴定出26个完整的O-糖肽,与LC相比,其中大多数在HCC中升高。其中,Hp上的HYEGS TVPEK(H1N1S1)在HCC患者中的强度最高。使用基于O/O C末端标记和多反应监测的MS方法对HCC中增加的HYEGS TVPEK(H1N1S1)进行了定量和确认。本研究全面了解了肝脏疾病中Hp的糖基化情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/3f9088d5f4da/fchem-09-705341-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/e2d520c705de/fchem-09-705341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/032fed916ad0/fchem-09-705341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/8814a9683a8c/fchem-09-705341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/0774bffcd47d/fchem-09-705341-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/3f9088d5f4da/fchem-09-705341-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/e2d520c705de/fchem-09-705341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/032fed916ad0/fchem-09-705341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/8814a9683a8c/fchem-09-705341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/0774bffcd47d/fchem-09-705341-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1df/8316590/3f9088d5f4da/fchem-09-705341-g005.jpg

相似文献

1
Quantification of Intact O-Glycopeptides on Haptoglobin in Sera of Patients With Hepatocellular Carcinoma and Liver Cirrhosis.肝细胞癌和肝硬化患者血清中触珠蛋白上完整O-糖肽的定量分析
Front Chem. 2021 Jul 14;9:705341. doi: 10.3389/fchem.2021.705341. eCollection 2021.
2
Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.慢性丙型肝炎、丙型肝炎所致肝硬化及肝细胞癌患者的糖基化改变、血清触珠蛋白和α-1-抗胰蛋白酶表达情况
Glycoconj J. 2016 Apr;33(2):209-18. doi: 10.1007/s10719-016-9658-2. Epub 2016 Mar 31.
3
Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.血清触珠蛋白中的糖肽生物标志物用于非酒精性脂肪性肝炎患者肝细胞癌的检测
J Proteome Res. 2020 Aug 7;19(8):3452-3466. doi: 10.1021/acs.jproteome.0c00270. Epub 2020 May 29.
4
Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.基于糖蛋白质组学和凝集素免疫分析的血清触珠蛋白在乙型肝炎病毒感染相关肝脏疾病中的分析。
Clin Chim Acta. 2019 Aug;495:309-317. doi: 10.1016/j.cca.2019.04.072. Epub 2019 Apr 20.
5
Analysis of Serum Paraoxonase 1 Using Mass Spectrometry and Lectin Immunoassay in Patients With Alpha-Fetoprotein Negative Hepatocellular Carcinoma.采用质谱法和凝集素免疫分析法对甲胎蛋白阴性肝细胞癌患者血清对氧磷酶1的分析
Front Oncol. 2021 Apr 6;11:651421. doi: 10.3389/fonc.2021.651421. eCollection 2021.
6
Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.通过全质谱扫描傅里叶变换离子回旋共振质谱(FT-ICR)和多反应监测对结直肠癌和肝细胞癌患者中N-糖肽和O-糖肽表达变化的定量分析。
J Proteomics. 2017 Feb 5;153:44-52. doi: 10.1016/j.jprot.2016.09.004. Epub 2016 Sep 16.
7
PRM-MS Quantitative Analysis of Isomeric -Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma.肝硬化和肝细胞癌患者血清触珠蛋白衍生的异构糖肽的PRM-MS定量分析
Metabolites. 2021 Aug 23;11(8):563. doi: 10.3390/metabo11080563.
8
Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.采用 LC-EThcD-MS/MS 技术对肝癌和肝硬化患者血清触珠蛋白中特定位点完整 N-糖肽的差异定量测定
J Proteome Res. 2019 Jan 4;18(1):359-371. doi: 10.1021/acs.jproteome.8b00654. Epub 2018 Oct 29.
9
Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.发现用于肝细胞癌早期诊断的触珠蛋白糖肽生物标志物 panel。
Front Oncol. 2023 Oct 18;13:1213898. doi: 10.3389/fonc.2023.1213898. eCollection 2023.
10
Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.定量分析肝脏疾病患者血清触珠蛋白β链上的糖基化位点特异性 N-聚糖。
Acta Biochim Biophys Sin (Shanghai). 2013 Dec;45(12):1021-9. doi: 10.1093/abbs/gmt110. Epub 2013 Oct 8.

引用本文的文献

1
In-silico structural and functional analysis of nonsynonymous single nucleotide polymorphisms in human gene.人类基因非同义单核苷酸多态性的计算机结构与功能分析
In Silico Pharmacol. 2025 Feb 25;13(1):32. doi: 10.1007/s40203-025-00319-3. eCollection 2025.
2
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.自上而下蛋白质组学鉴定肝硬化进展的血浆蛋白质异构体特征
Mol Cell Proteomics. 2024 Dec;23(12):100876. doi: 10.1016/j.mcpro.2024.100876. Epub 2024 Nov 8.
3
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.

本文引用的文献

1
Recent Advances in Analytical Approaches for Glycan and Glycopeptide Quantitation.聚糖和糖肽定量分析方法的最新进展。
Mol Cell Proteomics. 2021;20:100054. doi: 10.1074/mcp.R120.002095. Epub 2021 Feb 20.
2
Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases.蛋白质糖基化作为慢性炎症性胃肠道和肝脏疾病的诊断和预后标志物。
Gastroenterology. 2020 Jan;158(1):95-110. doi: 10.1053/j.gastro.2019.08.060. Epub 2019 Oct 15.
3
N-glycopeptide Signatures of IgA in Serum from Patients with Hepatitis B Virus-related Liver Diseases.
自上而下蛋白质组学确定肝硬化进展的血浆蛋白变体特征。
bioRxiv. 2024 Jun 19:2024.06.19.599662. doi: 10.1101/2024.06.19.599662.
4
Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions.一种用于鉴别甲胎蛋白阴性肝脏良恶性占位性病变的可靠GADSAH模型的开发
J Hepatocell Carcinoma. 2024 Mar 23;11:607-618. doi: 10.2147/JHC.S452628. eCollection 2024.
5
Diagnostic and Prognostic Value of Protein Post-translational Modifications in Hepatocellular Carcinoma.蛋白质翻译后修饰在肝细胞癌中的诊断和预后价值
J Clin Transl Hepatol. 2023 Oct 28;11(5):1192-1200. doi: 10.14218/JCTH.2022.00006S. Epub 2023 Apr 4.
6
Strategies for Proteome-Wide Quantification of Glycosylation Macro- and Micro-Heterogeneity.蛋白质组范围糖基化宏观和微观异质性的定量策略。
Int J Mol Sci. 2022 Jan 30;23(3):1609. doi: 10.3390/ijms23031609.
7
Methods for quantification of glycopeptides by liquid separation and mass spectrometry.通过液分离和质谱法对糖肽进行定量的方法。
Mass Spectrom Rev. 2023 Mar;42(2):887-917. doi: 10.1002/mas.21771. Epub 2022 Feb 4.
乙型肝炎病毒相关肝病患者血清中 IgA 的 N-糖肽特征。
Mol Cell Proteomics. 2019 Nov;18(11):2262-2272. doi: 10.1074/mcp.RA119.001722. Epub 2019 Sep 9.
4
A global view of hepatocellular carcinoma: trends, risk, prevention and management.全球视角下的肝细胞癌:趋势、风险、预防与管理。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22.
5
Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.基于质谱的肝细胞癌糖蛋白质组学标志物。
Mass Spectrom Rev. 2019 May;38(3):265-290. doi: 10.1002/mas.21583. Epub 2018 Nov 25.
6
Mapping the O-glycoproteome using site-specific extraction of O-linked glycopeptides (EXoO).利用 O-连接糖肽的特异性提取(EXoO)绘制 O-糖蛋白组图谱。
Mol Syst Biol. 2018 Nov 20;14(11):e8486. doi: 10.15252/msb.20188486.
7
Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.采用 LC-EThcD-MS/MS 技术对肝癌和肝硬化患者血清触珠蛋白中特定位点完整 N-糖肽的差异定量测定
J Proteome Res. 2019 Jan 4;18(1):359-371. doi: 10.1021/acs.jproteome.8b00654. Epub 2018 Oct 29.
8
iProX: an integrated proteome resource.iProX:一个综合蛋白质组资源库。
Nucleic Acids Res. 2019 Jan 8;47(D1):D1211-D1217. doi: 10.1093/nar/gky869.
9
Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.通过 EThcD 和 HCD 质谱法对人类血清糖蛋白组中单糖和多糖肽进行系统分析。
J Proteomics. 2018 Jan 6;170:14-27. doi: 10.1016/j.jprot.2017.09.014. Epub 2017 Sep 29.
10
pGlyco 2.0 enables precision N-glycoproteomics with comprehensive quality control and one-step mass spectrometry for intact glycopeptide identification.pGlyco 2.0 可实现具有全面质量控制的精准 N-糖蛋白质组学,并通过一步质谱法对完整糖肽进行鉴定。
Nat Commun. 2017 Sep 5;8(1):438. doi: 10.1038/s41467-017-00535-2.